ALN [Planet Green] 8-K: (Original Filing)
[]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Comments on SEC Findings Against Jiaqiang "Chiang" Li and 1Globe Capital SEC Order found Li and 1Globe Violated SEC Rules and Federal Securities Laws by Failing to Disclose Key Facts regarding their Holdings of Sinovac The SEC also found that the participants in the activist plan were advise]
SVA [SINOVAC BIOTECH] 6-K: Sinovac Comments on SEC Findings Against Jiaqiang “Chiang”
[Sinovac Comments on SEC Findings Against Jiaqiang "Chiang" Li and 1Globe Capital SEC Order found Li and 1Globe Violated SEC Rules and Federal Securities Laws by Failing to Disclose Key Facts regarding their Holdings of Sinovac The SEC also found that the participants in the activist plan were advise]
CEA [CHINA EASTERN AIRLINES] 6-K: (Original Filing)
[China Eastern Airlines Corporation Limited Date May 18, 2020 By]
CEA [CHINA EASTERN AIRLINES] 6-K: China Eastern Airlines Corporation Limited Date May 18,
[China Eastern Airlines Corporation Limited Date May 18, 2020 By]
SEED [Origin Agritech] 6-K: (Original Filing)
[FINANCIAL RESULTS OVERVIEW The Company reported net revenue of RMB44.1 million (US$6.3 million) during the first half year of FY2020, compared to RMB82.2 million for the first half year of FY2019. Total operating expenses for the first half year of FY2020 was RMB10.5 million (US$1.5 million), down 4]
SEED [Origin Agritech] 6-K: FINANCIAL RESULTS OVERVIEW The Company reported net revenue
[FINANCIAL RESULTS OVERVIEW The Company reported net revenue of RMB44.1 million (US$6.3 million) during the first half year of FY2020, compared to RMB82.2 million for the first half year of FY2019. Total operating expenses for the first half year of FY2020 was RMB10.5 million (US$1.5 million), down 4]
OSN [Ossen Innovation] 20-F: (Original Filing)
[] [DESCRIPTION OF SECURITIES Defined terms used herein and not defined herein shall have the meaning ascribed to such terms in the Company’s Annual Report on Form 20-F. Ordinary Shares Rights of Shares We are currently authorized to issue 100,000,000 ordinary shares. The shares are made up of one cl]
OSN [Ossen Innovation] 20-F:
[] [DESCRIPTION OF SECURITIES Defined terms used herein and not defined herein shall have the meaning ascribed to such terms in the Company’s Annual Report on Form 20-F. Ordinary Shares Rights of Shares We are currently authorized to issue 100,000,000 ordinary shares. The shares are made up of one cl]
